Skip to main content
. 2016 Oct 21;7(12):1191–1196. doi: 10.1021/acsmedchemlett.6b00289

Table 1. Antibacterial Activity of Compounds 11, 12, 19, 22, and 24 against Clinical MSSA and MRSA Strains.

graphic file with name ml-2016-00289f_0006.jpg

  minimum inhibitory concentration (μg/mL)
  MSSAa MRSAb
compd M056 M013 N043 C217 Y069 L166 Z234 4N216
11 1–2 1 1 1 1 1 1 1
12 1 1 1 1 1 1 1 1
19 1 1 1 1 1 1 1 0.5
22 1 1 1 1 1 1 1 1
24 1 4 4 4 4 4 4 0.5–1
vancomycin 2 ≤0.5 1 1 1 2 1 1
a

Clinical MSSA strain M056.

b

Clinical MRSA strains M013, N043, C217, Y069, L166, Z234, and 4N216.